From the Back Cover
From the ancients to the Renaissance, religion and medicine worked hand in hand to heal the people, until the scientific minds of the Enlightenment created a physical model of illness without a spiritual component. In this century, spirituality is gaining recognition as part of individuals' psychological makeup and capacity for meaning-making, and gaining currency as part of holistic concepts of wellness despite resistance from many in the scientific community.
Prayer: Investigating Its Impact on Quality of Life brings science and spirituality together, pointing out thought-provoking parallels and asserting that each can enrich the other. At the book's center is a detailed study of a randomized double-blinded trial that added intercessory prayer (i.e., prayer for others) to conventional cancer treatment, with findings relevant to conceptions of prayer as intervention. In addition, a review of salient medical literature (including complementary and alternative medical journals) contains both positive and negative studies, encouraging a vigorous dialogue about methodology, endpoints, and whether metaphysical phenomena can--or should--be studied using scientific methods. Among the topics covered:
- The role of spirituality in illness.
- Prayer as complementary or alternative therapy.
- The relationship between spiritual wellbeing and quality of life.
- Instruments for assessing religious and spiritual belief.
- A randomized blinded study of intercessory prayer in patients with cancer.
- Possible directions for further research.
Prayer: Investigating Its Impact on Quality of Life should interest readers on all sides of the debate, including doctors, practitioners, psychologists, psychiatrists, and others involved in holistic treatment of patients.
Ian Olver, MD, PhD, is a Fellow of the Royal Australasian College of Physicians, its Chapter of Palliative Medicine, and is a member of the Royal Australian College of Medical Administrators. He completed a PhD from Monash University in bioethics, exploring life and death issues, and a Certificate of Ministry at the Adelaide College of Divinity. He trained in medical oncology at Peter MacCallum Cancer Institute, the Alfred Hospital in Melbourne, and the University of Maryland Cancer Center in Baltimore. In 2006 he was appointed CEO, Cancer Council Australia, a Clinical Professor in the Department of Medicine at the University of Sydney, and he is an Honorary Associate, Department of Medical Oncology, Royal Prince Alfred Hospital. After serving on several ethics committees in Victoria and South Australia and the American society of Clinical Oncology Ethics Committee, and chairing the Cancer Institute NSW Research Ethics Committee for multicenter cancer trials, he now sits on the Australian Health Ethics committee of the NHMRC and chairs the Medical Oncology Group of the Australia Ethics Committee. In 2008 he was awarded the Cancer Achievement Aware by the Medical Oncology Group of Australia.
